Arkolith/Insider Trading/OVID

OVID Insider Trading

Ovid Therapeutics Inc. · full profile →Last filing Jul 6, 2026
Net Selling · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$29K
2 insiders
Net Insider Flow
-$29K
open market, 180d
Reporting Insiders
2
2 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jul 6, 2026Carter Charles RossChief Financial OfficerGrant(A)50K—$0
Jun 15, 2026Greka AnnaDirectorGrant(A)130K—$0
Apr 7, 2026Friedman BartDirectorGrant(A)9K$2.56$22K
Apr 7, 2026Fitzgerald Kevin JosephDirectorGrant(A)18K$2.56$45K
Apr 7, 2026Papadopoulos SteliosDirectorGrant(A)18K$2.56$45K
Mar 23, 2026Levin Jeremy MExecutive Chairman, DirectorOption exercise(M)47K$1.40$66K
Mar 23, 2026Levin Jeremy MExecutive Chairman, DirectorOption exercise(M)47K—$0
Feb 26, 2026Papadopoulos SteliosDirectorGrant(A)65K—$0
Feb 26, 2026Levin Jeremy MDirectorGrant(A)957K—$0
Feb 26, 2026Rona Jeffrey ACBFOGrant(A)68K—$0
Feb 26, 2026Rona Jeffrey ACBFOGrant(A)409K—$0
Feb 26, 2026Duncan Barbara GayleDirectorGrant(A)65K—$0
Feb 26, 2026Friedman BartDirectorGrant(A)65K—$0
Feb 26, 2026Bernstein KarenDirectorGrant(A)65K—$0
Feb 26, 2026Fitzgerald Kevin JosephDirectorGrant(A)65K—$0
Feb 26, 2026Alexander Margaret A.President and CEO, DirectorGrant(A)1.4M—$0
Feb 23, 2026Rona Jeffrey ACBFOSell(S)9K$1.45$12K
Feb 23, 2026Alexander Margaret A.President and CEO, DirectorSell(S)12K$1.45$17K
Jan 4, 2026Alexander Margaret A.President and CEO, DirectorGrant(A)890K—$0
Dec 15, 2025Levin Jeremy MCEO, DirectorConversion(C)71K——
Dec 15, 2025Levin Jeremy MCEO, DirectorConversion(C)71—$0
Dec 11, 2025Levin Jeremy MCEO, DirectorBuy(P)47K——
Dec 11, 2025Levin Jeremy MCEO, DirectorBuy(P)71——
Dec 11, 2025Levin Jeremy MCEO, DirectorBuy(P)36K——
Dec 8, 2025Takeda Pharmaceuticals U.S.A., Inc.10% OwnerConversion(C)1.3M—$0
Dec 8, 2025Takeda Pharmaceuticals U.S.A., Inc.10% OwnerConversion(C)1K—$0
Mar 3, 2025Papadopoulos SteliosDirectorGrant(A)90K—$0
Feb 26, 2025Rona Jeffrey ACBFOSell(S)4K$0.56$2K
Feb 26, 2025Alexander Margaret A.President and COOSell(S)5K$0.56$3K
Feb 20, 2025Bernstein KarenDirectorGrant(A)45K—$0
Feb 20, 2025Duncan Barbara GayleDirectorGrant(A)45K—$0
Feb 20, 2025Friedman BartDirectorGrant(A)45K—$0
Feb 20, 2025Fitzgerald Kevin JosephDirectorGrant(A)45K—$0
Feb 20, 2025Alexander Margaret A.President and COOGrant(A)44K—$0
Feb 20, 2025Alexander Margaret A.President and COOGrant(A)263K—$0
Feb 20, 2025Rona Jeffrey ACBFOGrant(A)44K—$0
Feb 20, 2025Rona Jeffrey ACBFOGrant(A)263K—$0
Feb 20, 2025Levin Jeremy MCEO, DirectorGrant(A)1.6M—$0
Jan 27, 2025Alexander Margaret A.President and COOBuy(P)7K$0.73$5K
Dec 12, 2024Bernstein KarenDirectorGrant(A)90K—$0
Dec 12, 2024Duncan Barbara GayleDirectorGrant(A)90K—$0
Dec 12, 2024Friedman BartDirectorGrant(A)90K—$0
Dec 12, 2024Fitzgerald Kevin JosephDirectorGrant(A)90K—$0
Sep 9, 2024Alexander Margaret A.President and COOGrant(A)140K—$0
Jul 30, 2024Rona Jeffrey ACBFOGrant(A)315K—$0
Mar 18, 2024Levin Jeremy MCEO, DirectorBuy(P)18K$2.76$50K
Feb 22, 2024Bernstein KarenDirectorGrant(A)30K—$0
Feb 22, 2024Duncan Barbara GayleDirectorGrant(A)30K—$0
Feb 22, 2024Fitzgerald Kevin JosephDirectorGrant(A)30K—$0
Feb 22, 2024Friedman BartDirectorGrant(A)30K—$0
Feb 22, 2024Levin Jeremy MCEO, DirectorGrant(A)700K—$0
Feb 22, 2024Perone Thomas MichaelGeneral Counsel, SecretaryGrant(A)28K—$0
Feb 22, 2024Perone Thomas MichaelGeneral Counsel, SecretaryGrant(A)169K—$0
Feb 22, 2024Poole Robert MichaelDirectorGrant(A)30K—$0
Feb 22, 2024Rona Jeffrey ACBFOGrant(A)28K—$0
Feb 22, 2024Rona Jeffrey ACBFOGrant(A)169K—$0
Feb 22, 2024Tardio JasonChief Operating OfficerGrant(A)28K—$0
Feb 22, 2024Tardio JasonChief Operating OfficerGrant(A)169K—$0
Dec 4, 2023Levin Jeremy MCEO, DirectorGift(G)573K—$0
Dec 4, 2023Levin Jeremy MCEO, DirectorGift(G)573K—$0
Feb 23, 2023Bernstein KarenDirectorGrant(A)15K—$0
Feb 23, 2023Duncan Barbara GayleDirectorGrant(A)15K—$0
Feb 23, 2023Fitzgerald Kevin JosephDirectorGrant(A)15K—$0
Feb 23, 2023Friedman BartDirectorGrant(A)15K—$0
Feb 23, 2023Levin Jeremy MCEO, Director, 10% OwnerGrant(A)600K—$0
Feb 23, 2023Perone Thomas MichaelGeneral Counsel, SecretaryGrant(A)175K—$0
Feb 23, 2023Poole Robert MichaelDirectorGrant(A)15K—$0
Feb 23, 2023Rona Jeffrey ACBFOGrant(A)175K—$0
Feb 23, 2023Tardio JasonChief Operating OfficerGrant(A)175K—$0
Sep 12, 2022Tardio JasonChief Operating OfficerSell(S)17K$2.15$37K
Jul 1, 2022Takeda Pharmaceutical Co Ltd10% OwnerOther(J)5.8M—$0
Jul 1, 2022Takeda Pharmaceutical Co Ltd10% OwnerOther(J)5.8M—$0
Jul 1, 2022Takeda Pharmaceutical Co Ltd10% OwnerOther(J)1K—$0
Jul 1, 2022Takeda Pharmaceutical Co Ltd10% OwnerOther(J)1K—$0
Apr 8, 2022Bernstein KarenDirectorGrant(A)69K—$0
Apr 8, 2022Duncan Barbara GayleDirectorGrant(A)21K—$0
Apr 8, 2022Perone Thomas MichaelGeneral Counsel, SecretaryGrant(A)25K—$0
Apr 8, 2022Perone Thomas MichaelGeneral Counsel, SecretaryGrant(A)10K—$0
Apr 8, 2022Rona Jeffrey ACBFOGrant(A)194K—$0
Apr 8, 2022Rona Jeffrey ACBFOGrant(A)10K—$0
Apr 8, 2022Levin Jeremy MCEO, Director, 10% OwnerGrant(A)423K—$0
Apr 8, 2022Tardio JasonChief Operating OfficerGrant(A)10K—$0
Apr 8, 2022Tardio JasonChief Operating OfficerGrant(A)87K—$0
Apr 8, 2022Friedman BartDirectorGrant(A)69K—$0
Feb 3, 2022Levin Jeremy MCEO, Director, 10% OwnerGrant(A)600K—$0
Feb 3, 2022Perone Thomas MichaelGeneral Counsel, SecretaryGrant(A)175K—$0
Feb 3, 2022Rona Jeffrey ACBFOGrant(A)219K—$0
Feb 3, 2022Tardio JasonChief Operating OfficerGrant(A)175K—$0
Feb 3, 2022Bernstein KarenDirectorGrant(A)15K—$0
Feb 3, 2022Duncan Barbara GayleDirectorGrant(A)15K—$0
Feb 3, 2022Fitzgerald Kevin JosephDirectorGrant(A)15K—$0
Feb 3, 2022Friedman BartDirectorGrant(A)15K—$0
Feb 3, 2022Poole Robert MichaelDirectorGrant(A)15K—$0
Oct 6, 2021Fitzgerald Kevin JosephDirectorGrant(A)30K—$0
Jul 14, 2021Rakhit AmitPresident and CMOOption exercise(M)34K$1.89$64K
Jul 14, 2021Rakhit AmitPresident and CMOSell(S)34K$3.71$126K
Jul 14, 2021Rakhit AmitPresident and CMOOption exercise(M)34K—$0
Jul 9, 2021Poole Robert MichaelDirectorGrant(A)30K—$0
Jul 1, 2021Tardio JasonChief Commercial OfficerGrant(A)50K—$0
Jun 11, 2021Bernstein KarenDirectorGrant(A)15K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2008-06-30 → 2026-08-15. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for OVID